Skip to main content
. 2014 Sep 9;20(Suppl 7):102–108. doi: 10.1111/1469-0691.12595

Table 1.

Recommendations on prevention of community‐acquired respiratory virus infection

SOT recipients should avoid close contact with individuals with respiratory tract infections. AII
All SOT recipients and candidates should receive annual seasonal influenza vaccination. AII
Household members and HCWs in contact with SOT recipients should also receive influenza vaccination. AII
Live‐attenuated influenza vaccine is not recommended in SOT recipients. DII
In selected patients to whom influenza vaccine cannot be administered, prophylaxis with oseltamivir 75 mg/day for 12 weeks during the influenza season may be proposed. CI
The use of palivizumab for prevention of respiratory syncytial virus infection is not recommended in SOT recipients. CIII

SOT, solid organ transplant; HCW, healthcare workers.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.